These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16276155)

  • 1. A practical comparison of hydroquinone-containing products for the treatment of melasma.
    Abramovits W; Barzin S; Arrazola P
    Skinmed; 2005; 4(6):371-6. PubMed ID: 16276155
    [No Abstract]   [Full Text] [Related]  

  • 2. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
    Astaneh R; Farboud E; Nazemi MJ
    Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and efficacy of a novel formulation in the treatment of melasma.
    Guevara IL; Werlinger KD; Pandya AG
    J Drugs Dermatol; 2010 Mar; 9(3):215-8. PubMed ID: 20232581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
    Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
    Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
    Grimes PE
    Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of retinoic acid in the treatment of melasma.
    Pathak MA; Fitzpatrick TB; Kraus EW
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
    Farshi S
    J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of melasma and the use of intense pulsed light: a review.
    Zaleski L; Fabi S; Goldman MP
    J Drugs Dermatol; 2012 Nov; 11(11):1316-20. PubMed ID: 23135081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
    Pekmezci E
    J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous ochronosis hydroquinone induced: a report of four cases.
    Ribas J; Schettini AP; Cavalcante Mde S
    An Bras Dermatol; 2010; 85(5):699-703. PubMed ID: 21152798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study.
    Nofal A; Ibrahim AM; Nofal E; Gamal N; Osman S
    J Cosmet Dermatol; 2019 Feb; 18(1):263-270. PubMed ID: 30146802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
    Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
    Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.